We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Editorial |

The Benefits of Lowering Cholesterol in Subjects With Mild Hyperglycemia

Ronald B. Goldberg, MD
Arch Intern Med. 1999;159(22):2627-2628. doi:10-1001/pubs.Arch Intern Med.-ISSN-0003-9926-159-22-ied90009.
Text Size: A A A
Published online


THE RECENT LOWERING of the fasting glucose level for the diagnosis of diabetes from 7.8 mmol/L (140 mg/dL) to 7.0 mmol/L (126 mg/dL) by the American Diabetes Association (ADA), as well as the definition of a new category—impaired fasting glucose (IFG)—defined as a fasting glucose level between 6.1 and 6.9 mmol/L (110 and 125 mg/dL) (mainly to circumvent the need to perform an oral glucose tolerance test to identify the state of impaired glucose tolerance [IGT]), draws attention to the consequences of mild elevations of the fasting plasma glucose level.1 It is estimated that about 5.3 million previously undiagnosed individuals with diabetes as well as a large proportion of the estimated 11.6 million people with IGT in the United States may now be identifiable through the application of these new criteria using the fasting plasma glucose test. Identifying diabetes at an earlier point in its course may have significant benefit, since earlier diagnosis and treatment of hyperglycemia will reduce the extent of microvascular complications, and hygienic measures applied to individuals with IGT may retard its progression to diabetes.


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

2 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.